SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 50.97 |
Enterprise Value ($M) | 77.65 |
Book Value ($M) | 5.78 |
Book Value / Share | 0.17 |
Price / Book | 8.83 |
NCAV ($M) | -5.39 |
NCAV / Share | -0.16 |
Price / NCAV | -9.45 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.71 |
Return on Assets (ROA) | -0.49 |
Return on Equity (ROE) | -1.11 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.60 |
Current Ratio | 1.60 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 32.37 |
Assets | 43.54 |
Liabilities | 37.77 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Armistice Capital, Llc | 8.66 | ||
13D/A | South Lake One, Llc | 28.20 | -31.57 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
112,142 | 458,767 | 24.44 | |
58,628 | 180,390 | 32.50 | |
48,096 | 199,143 | 24.15 | |
61,561 | 146,490 | 42.02 | |
(click for more detail) |
Similar Companies | |
---|---|
PAHC – Phibro Animal Health Corporation | PTGX – Protagonist Therapeutics, Inc. |
QTTB – Q32 Bio Inc. | RAPT – RAPT Therapeutics, Inc. |
RCKT – Rocket Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io